ArticleClinical and translational science2023

Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy.

Nicolas Hohmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.